Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company
About us
Contact us
1000002455
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

Kilitch Drugs

183.20 -0.25 (-0.14%) BSE

Buy Sell

Last updated on 16 Sep 2021 11:21 AM

Returns
(4.99%)
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

285.49

Earning Per Share

2.89

Dividend Yield

-%

P/E Ratio

28.11

P/B Ratio

1.75

Debt to Equity

0.07

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value

5.34% down side

up side5.34%


About the company

Incorporated in May '92 as a public limited company, Kilitch Drugs (India) (KDIL) went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.'95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical. A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America.

Similar Companies


Login